tiprankstipranks
Elementis PLC (EMNSF)
OTHER OTC:EMNSF
US Market

Elementis (EMNSF) Earnings Dates, Call Summary & Reports

13 Followers

Earnings Data

Report Date
Jul 30, 2026
TBA (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
Last Year’s EPS
0.07
Same Quarter Last Year
Based on 3 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Mar 05, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call shows a constructive transformation story: management delivered profit growth, margin expansion (+150 bps), strong Personal Care outperformance (revenue +2.4%, profit +16.9%, margin +410 bps), record innovation (16.4%) and continued cost-savings and sustainability progress. Offsetting these positives are modest revenue decline (-1.0% reported / -1.9% CC), Coatings weakness (revenue down ≈3.5% and margin compression), lower free cash flow ($41M vs $51M) and higher leverage (1.3x). Strategic portfolio moves (Alchemy acquisition, Talc sold, pharma disposal) sharpen focus and are accretive over time but change scale. On balance the highlights — margin expansion, EPS growth (+14.2%), successful cost programs, innovation momentum and clear strategic direction — slightly outweigh the near-term operational and macro headwinds.
Company Guidance
The management reiterated medium‑term guidance under the Elevate Elementis plan of mid‑single‑digit revenue growth, operating margins above 23%, 3‑year operating cash conversion >90% and ROCE (ex‑goodwill) >30%, alongside a target to lift innovation sales from 16.4% in 2025 toward 20%; near‑term technicals include 2026 CapEx of 4–5% of revenue, R&D rising from 2% to 3% of revenue (a 50% increase), a goal to reach ~1x net debt/EBITDA organically by end‑2026 (net debt/EBITDA was 1.3x at year‑end with net debt $185.4m), and a ~30% dividend payout policy (2025 full‑year dividend $0.043, final $0.03); 2025 results to keep in mind as context were revenue $597.5m (‑1% reported, ‑1.9% CC), adjusted operating profit $126.7m (+4.6%), adjusted margin 21.2% (+150bps), adjusted EPS $0.137 (+14.2%), free cash flow $41m, and the company expects to distribute net proceeds from the announced pharma disposal (pharma revenue $35m in the prior year); cost‑savings deliverables include $18m of self‑help savings in 2025, completion of elements of a $30m program ( ~$12m via Fit for the Future) plus an additional $10m target (of which $6m is already delivered, $4m to come by end‑2026), while operational targets include a 20% improvement at St. Louis (two‑thirds of a 30% unlock) and achieving half of a 20% On‑Time‑In‑Full uplift.
Adjusted Operating Profit Growth and Margin Expansion
Adjusted operating profit increased 4.6% to $126.7M and group adjusted operating margin improved 150 basis points to 21.2%, demonstrating margin resilience despite a softer demand environment.
Earnings Per Share and Shareholder Returns
Adjusted EPS rose 14.2% to $0.137. The Board recommended a final dividend of $0.03, taking full-year dividend to $0.043 (up 7.5%) and a payout ratio of 31%. The company completed a buyback that cancelled ~4% of issued share capital.
Personal Care Outperformance
Personal Care revenue grew 2.4% to $224.5M; adjusted operating profit rose 16.9% to $72.8M and segment margin expanded 410 basis points to 32.4%, driven by improved volumes, pricing and cost savings.
Portfolio Simplification and Strategic Divestments
Continued transformation into a pure-play specialty chemicals business: Talc previously sold, Chromium exited in 2023, and an agreement reached to sell the pharmaceutical manufacturing business (pharma revenue $35M in prior year). These actions reduce capital intensity and improve pro forma margins.
Bolt-On Acquisition — Alchemy
Acquired Alchemy in November for $20.1M — a bolt-on in Personal Care that is fast-growing, high-margin and strategically synergistic with hectorite and rheology capabilities.
Innovation and R&D Momentum
Innovation sales reached a record 16.4% (doubled over five years); launched 19 new products and sent 1,500+ samples. R&D investment planned to increase from 2% to 3% of revenue, with a medium-term innovation sales target of 20%.
Safety and Sustainability Progress
Achieved first 0 lost time accidents since 2019. Carbon footprint reduced by nearly 80% versus 2019 (divestments and operational changes). Hectorite mine moved to almost entirely renewable energy from a 0% base the prior year.
Cost Savings and Operational Improvements
Delivered $18M of self-help/cost savings in the year; completed the balance of a 2-year $30M program and started an additional $10M program (already delivered $6M, remaining $4M planned by end-2026). Debottlenecking at St. Louis delivered a 20% improvement since H1.

Elementis (EMNSF) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

EMNSF Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 30, 2026
2026 (Q2)
- / -
0.068
Mar 05, 2026
2025 (Q4)
- / 0.07
0.05721.05% (+0.01)
Jul 31, 2025
2025 (Q2)
0.07 / 0.07
0.078-12.82% (>-0.01)
Mar 06, 2025
2024 (Q4)
0.06 / 0.06
0.04916.33% (<+0.01)
Aug 01, 2024
2024 (Q2)
0.06 / 0.08
0.05639.29% (+0.02)
Mar 07, 2024
2023 (Q4)
0.05 / 0.05
0.053-7.55% (>-0.01)
Jul 27, 2023
2023 (Q2)
0.05 / 0.06
0.071-21.13% (-0.01)
Mar 07, 2023
2022 (Q4)
0.05 / 0.05
-0.032265.62% (+0.08)
Aug 02, 2022
2022 (Q2)
- / 0.07
0.05529.09% (+0.02)
Mar 03, 2022
2021 (Q4)
0.04 / -0.04
-0.028-52.38% (-0.01)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

EMNSF Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Mar 05, 2026
$2.16$2.13-1.39%
Jul 31, 2025
$2.12$2.22+4.58%
Mar 06, 2025
$1.89$1.87-0.74%
Aug 01, 2024
$2.00$1.99-0.25%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Elementis PLC (EMNSF) report earnings?
Elementis PLC (EMNSF) is schdueled to report earning on Jul 30, 2026, TBA (Confirmed).
    What is Elementis PLC (EMNSF) earnings time?
    Elementis PLC (EMNSF) earnings time is at Jul 30, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is EMNSF EPS forecast?
          Currently, no data Available